Novo CEO pressed by Senate to cut price ranges of weight problems, diabetic issues prescription drugs CEO Lars Fruergaard Jørgensen told lawmakers the corporation would contemplate new talks with insurers with regard to the list charges of Wegovy and copyright should they pledge to keep the medicines on their formularies. https://louiststro.activoblog.com/31720961/everything-about-healthcare-news